Navigation Links
Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
Date:8/6/2009

MORRISTOWN, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Watson's pending acquisition of privately held Arrow Group. The information request was issued under notification requirements of the Hart.Scott.Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act"). The effect of the second request is to extend the waiting period imposed by the HSR Act until 30 days after Watson and Arrow Group have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC. Watson intends to cooperate fully with the FTC's review and continues to expect the transaction to close in the second half of 2009.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forwar
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... A recent University College London (UCL) ... the dental community disagrees on the best way to ... of dental advice suggested that some six different tooth-brushing ... more popular than the rest. , “The easiest ... floss your teeth regularly,” said Dr. Alexandre-Amir Aalam, DDS, ...
(Date:8/27/2014)... "It can be quite difficult to wipe one’s ... inventor from Lehigh Acres, Fla.," so I designed an ... task." He then created a prototype of his idea. ... to wipe and clean the behind thoroughly after going ... well as prevents direct contact with waste or anal ...
(Date:8/27/2014)... Neil Haley, the Total Tutor host of the ... out about the importance of capacity to grow a business. ... ViSalus and is now a 5 Star Ambassador, Vi Millionaire, ... book titled "The Playful and Powerful Warrior Within You!" and ... working out for over 1000 days straight. He is ...
(Date:8/27/2014)... City, Utah (PRWEB) August 27, 2014 ... advancing the business of healthcare, is pleased to ... a ground-breaking online recruitment resource specifically designed for ... is undergoing significant changes. To help address the ... workforce, and tighter budgets—AAPC launched CareerHealth.com . ...
(Date:8/27/2014)... IntelliSoft Group, LLC, a leading provider of credentialing, ... IntelliCred, IntelliApp and IntelliContract Version 14.2 at ... Annual Conference on September 16, 2014 at the SERESC ... improvements available in IntelliSoft’s Version 14.2 healthcare ... A new Contract Connection Tab connects the healthcare provider ...
Breaking Medicine News(10 mins):Health News:Americans Confused About How to Brush Teeth 2Health News:InventHelp Client's Device Helps a User Wipe Thoroughly After Going to the Bathroom (HLW-1300) 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 2Health News:AAPC Responds to Healthcare Workforce Challenges with CareerHealth.com 3Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2
... pressure as it has been urged to make emergency contraception ... Eschenbach, acting Commissioner of the FDA has been urged to ... to sell its morning after pill or Plan B without ... set of two pills that can prevent pregnancy if taken ...
... arrested for allegedly selling fake question papers of the Combined ... 17 districts in the state today, police said. ... held here for selling CPMT question papers, which later turned ... of K G Dental University, which organised the CPMT examinations ...
... drugs seem to hold many youth under a spell. Recent ... to the tune of an increase of 400%, ever since ... reiterated the need for specialized services to remedy this menace, ... the University of Glasgow, said: "These figures are shocking and ...
... is to be conducted among children in the age group ... the kids are following proper eating habits// and there by ... mainly to tackle the worsening health crisis. But the Children's ... the child’s parents about the test results would stigmatize some ...
... is the second most deadly cancer among women. Statistics reveals ... result of cervical cancer. Hence researchers were keen on finding ... way to the development of a vaccine with the potential ... cervical cancer. ,It is mainly caused by ...
... conducted at New York indicates that people suffering from symptomatic ... C// and manganese than their counterparts without the problem. ... Dr N. J. Wareham et al of Medical Research Council ... reduce the onset of asthma. ,This study revealed ...
Cached Medicine News:
(Date:8/26/2014)... Research and Markets  has announced the addition of ... report to their offering. Intranasal drug delivery ... of drugs for the treatment of local diseases in ... non-allergic rhinitis and sinusitis. The nose is considered to ... systematic drug delivery. Continuous technological advancement ...
(Date:8/26/2014)... , Aug. 26, 2014   Quanta Aesthetic Lasers , ... North America , expands the offerings in their robust ... which is now available for shipping to medical spas, clinics, ... . The QuantaShape is manufactured in the Chianti ... General Project .  The device was previously sold as both ...
(Date:8/26/2014)...  When it comes to diabetes supplies, innovations are often ... happens to answer a real medical need. ... market, Timesulin shows how long it,s been since your ... or double insulin doses. Very easy to use, Timesulin ... insulin pen after an injection. There is no settings ...
Breaking Medicine Technology:Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup 2Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2
... Popular antidepressants taken with tamoxifen can increase the risk ... May 30 A new study found that taking ... of breast cancer recurrence in women taking both medications. ... work effectively.(Logo: http://www.newscom.com/cgi-bin/prnh/20090530/DC24767LOGO ) ...
... Abstract # 25670ORLANDO, Fla., May 29 ... has selected new breast cancer research conducted ... in Detroit for posting on ASCO,s Web ... promising new therapeutic target for aggressive hormone ...
Cached Medicine Technology:New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... Nellcor's most popular handheld oximeter has ... Oximetry platform and is now compatible with ... including the MAX-FAST Forehead Sensor and SoftCare ... Pulse Oximeter also incorporates Nellcor's latest advanced ...
... expanding the growing portfolio of OxiMax® ... is a compact, affordable bedside monitor. ... processing technology, it offers reliable operation ... compatible with the complete family of ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
Medicine Products: